Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.

Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program. Haematologica. 2018 Feb 01;: Authors: Hillmen P, Diels J, Healy N, Iraqi W, Aschan J, Wildgust M PMID: 29419428 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29419428?dopt=Abstract

Source: Haematologica - February 1, 2018 Category: Hematology Authors: Hillmen P, Diels J, Healy N, Iraqi W, Aschan J, Wildgust M Tags: Haematologica Source Type: research

More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Iraq Health | Leukemia